nifedipine has been researched along with cysteine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cuccaro, ML; Jacobs, LS; Lorenson, MY | 1 |
| Bates, JN; Hoque, A; Lewis, SJ; Travis, MD | 1 |
| Bates, JN; Bhopatkar, MY; Lewis, SJ; Walton, TM | 1 |
| Araki, N; Imabayashi, E; Kuji, I; Matsuda, H; Ohkubo, T; Shimazu, K | 1 |
| Arienti, G; Mazzoni, M; Palmerini, CA; Saccardi, C | 1 |
| Crawford, JJ; MacFaul, PA; Morley, AD | 1 |
| Blood, AB; Liu, T; Longo, LD; Power, GG; Schroeder, HJ; Terry, MH; Wilson, SM; Zhang, M | 1 |
1 review(s) available for nifedipine and cysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for nifedipine and cysteine
| Article | Year |
|---|---|
Calcium release from pituitary secretory granules: modulation by thiols, disulfides, and dihydropyridine calcium channel blockers.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Cattle; Cysteine; Cystine; Cytoplasmic Granules; Dihydropyridines; Disulfides; Dithiothreitol; Glutathione; Hydrogen-Ion Concentration; Mercaptoethanol; Nifedipine; Nimodipine; Pituitary Gland; Potassium Chloride; Sulfhydryl Compounds | 1990 |
Blockade of voltage-sensitive Ca(2+)-channels markedly diminishes nitric oxide- but not L-S-nitrosocysteine- or endothelium-dependent vasodilation in vivo.
Topics: Acetylcholine; Animals; Calcium Channel Blockers; Calcium Channels; Cysteine; Endothelium, Vascular; Hemodynamics; Hydrazines; Indomethacin; Male; Nifedipine; Nitric Oxide; Nitroprusside; Nitroso Compounds; Rats; Rats, Sprague-Dawley; S-Nitrosothiols; Sodium Chloride; Vasodilation; Vasodilator Agents | 2000 |
Role of voltage-sensitive calcium-channels in nitric oxide-mediated vasodilation in spontaneously hypertensive rats.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Cysteine; Diltiazem; Hindlimb; Hydrazines; Male; Muscle, Smooth, Vascular; Nifedipine; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Rats; Rats, Inbred SHR; Rats, Inbred WKY; S-Nitrosothiols; Vascular Resistance; Vasodilation; Vasodilator Agents; Verapamil | 2005 |
Effect of nilvadipine on regional cerebral blood flow in a patient with early Alzheimer disease.
Topics: Aged, 80 and over; Alzheimer Disease; Antihypertensive Agents; Cerebrovascular Circulation; Cysteine; Female; Humans; Hypertension; Nifedipine; Organotechnetium Compounds; Radiopharmaceuticals; Regional Blood Flow; Tomography, Emission-Computed, Single-Photon | 2008 |
The cytosolic calcium concentration is affected by S-nitrosocysteine in human lymphomonocytes.
Topics: Calcium; Calcium Signaling; Cysteine; Cytosol; Humans; Lymphocytes; Monocytes; Nifedipine; S-Nitrosothiols; Thapsigargin; Time Factors | 2008 |
A simple in vitro assay for assessing the reactivity of nitrile containing compounds.
Topics: Cysteine; Drug Discovery; Glutathione; Molecular Structure; Nifedipine; Nitriles | 2009 |
S-nitrosothiols dilate the mesenteric artery more potently than the femoral artery by a cGMP and L-type calcium channel-dependent mechanism.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cyclic GMP; Cysteine; Diltiazem; Female; Femoral Artery; Fetus; Indazoles; Male; Mesenteric Arteries; Nifedipine; Oxadiazoles; Quinoxalines; S-Nitrosoglutathione; S-Nitrosothiols; Sheep; Soluble Guanylyl Cyclase; Vasodilation; Vasodilator Agents | 2016 |